天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

IL-13試劑盒,IL-13 ELISA Kit
  • IL-13試劑盒,IL-13 ELISA Kit
  • IL-13試劑盒,IL-13 ELISA Kit
  • IL-13試劑盒,IL-13 ELISA Kit

IL-13 ELISA試劑盒-ACROBiosystems百普賽斯

價(jià)格 詢價(jià)
包裝 1支 5支 10支
最小起訂量 1支
發(fā)貨地 北京
更新日期 2024-12-16
微信洽談

產(chǎn)品詳情

中文名稱:IL-13試劑盒英文名稱:IL-13 ELISA Kit
品牌: 百普賽斯產(chǎn)地: 北京
保存條件: -20°C to -70°C純度規(guī)格: 99.9%
產(chǎn)品類別: ELISA試劑盒
數(shù)量: 999保質(zhì)期: 12個(gè)月
貨號(hào): EP-149是否進(jìn)口:
適應(yīng)物種: Human
2024-12-16 IL-13試劑盒 IL-13 ELISA Kit 1支/RMB;5支/RMB;10支/RMB 百普賽斯 北京 -20°C to -70°C 99.9% ELISA試劑盒

IL-13RA2 [Biotinylated] : IL-13 Inhibitor Screening ELISA Kit

1.jpg

背景(Background

Interleukin-13 receptor subunit alpha-2 is also known as IL13Rα2, IL13Ra2 cluster of differentiation 213A2, CD213A2, CT19, IL-13R, IL13BP, and is a membrane bound protein that in humans is encoded by the IL13RA2 gene. IL13Rα2 is closely related to IL13Rα1, a subunit of the interleukin-13 receptor complex. This protein binds IL13 with high affinity, but lacks any significant cytoplasmic domain, and does not appear to function as a signal mediator. It is, however able to regulate the effects of both IL13 and IL4, despite the fact it is unable to bind directly to the latter. It is also reported to play a role in the internalization of IL13. IL13Rα2 is a component of the cell surface receptors, however, the majority exists in intracellular pools and in soluble form, and thus plays an opposite role as a potent IL13 antagonist compared with IL13Rα1. It also functions as an inhibitor of IL4-dependent pathway probably through the physical interaction between the short intracellular domain of and cytoplasmic domain of IL13Rα2 and the IL4Rα chain. In spite of the failed STAT signaling function, IL13Rα2 dose induce TGF-beta production and fibrosis. Additionally, IL13Rα2has been reported to be abundantly and specifically overexpressed in glioblastoma multiforme.

原理(Assay Principles

This inhibitor screening ELISA kit is designed to facilitate the identification and characterization of new IL-13 R alpha 2 pathway inhibitors. The assay takes advantage of our in house-developed binding of biotinylated human IL-13 R alpha 2 to immobilized human IL-13 in a functional ELISA assay, and employs a simple colorimetric ELISA platform. Briefly, we provide you with a human Biotinylated IL-13 R alpha 2 protein, a human IL-13 protein, an anti-IL-13 R alpha 2 neutralizing antibody (as method verified Std.), and Streptavidin-HRP reagent.

Your experiment will include 4 simple steps:

a) Coat the plate with human IL-13.

b) Add your molecule of interest to the tests.

c) Add human IL-13 R alpha 2-Biotin to bind the coated IL-13.

d) Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.

e) Finally, the half maximal inhibitory concentration (IC50) of your compound to IL-13 R alpha 2: IL-13 binding will be determined by comparing OD readings among different experimental groups.

應(yīng)用說(shuō)明(Application

This kit is developed for screening for inhibitors of human IL-13 binding to human IL-13RA2.

It is for research use only.

重構(gòu)方法(Reconstitution

Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.

存儲(chǔ)(Storage

Unopened kit should be stored at 2°C-8°C upon receiving. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

2.jpg

關(guān)鍵字: IL-13 ELISA Kit;IL-13試劑盒;IL-13 ELISA試劑盒;ACRO;百普賽斯;

公司簡(jiǎn)介

百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。
成立日期 2010-07-22 (15年) 注冊(cè)資本 8000萬(wàn)人民幣
員工人數(shù) 500人以上 年?duì)I業(yè)額 ¥ 1億以上
主營(yíng)行業(yè) 醫(yī)藥中間體,原料藥,激素類,氨基糖苷類,中樞神經(jīng)系統(tǒng)用藥 經(jīng)營(yíng)模式 工廠,試劑
  • 北京百普賽斯生物科技股份有限公司
VIP 2年
  • 公司成立:15年
  • 注冊(cè)資本:8000萬(wàn)人民幣
  • 企業(yè)類型:其他股份有限公司(上市)
  • 主營(yíng)產(chǎn)品:重組蛋白,抗原,抗體,試劑盒
  • 公司地址:北京市北京經(jīng)濟(jì)技術(shù)開(kāi)發(fā)區(qū)宏達(dá)北路8號(hào)4幢4層
詢盤

IL-13 ELISA試劑盒-ACROBiosystems百普賽斯相關(guān)廠家報(bào)價(jià)

產(chǎn)品名稱 價(jià)格   公司名稱 報(bào)價(jià)日期
¥2496
VIP4年
上海博爾森生物科技有限公司
2024-12-27
¥2928
VIP4年
上海博爾森生物科技有限公司
2024-12-27
¥2640
VIP4年
上海博爾森生物科技有限公司
2024-12-27
¥2564
VIP4年
上海博爾森生物科技有限公司
2024-12-27
內(nèi)容聲明:
以上所展示的信息由商家自行提供,內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布商家負(fù)責(zé)。 商家發(fā)布價(jià)格指該商品的參考價(jià)格,并非原價(jià),該價(jià)格可能隨著市場(chǎng)變化,或是由于您購(gòu)買數(shù)量不同或所選規(guī)格不同而發(fā)生變化。最終成交價(jià)格,請(qǐng)咨詢商家,以實(shí)際成交價(jià)格為準(zhǔn)。請(qǐng)意識(shí)到互聯(lián)網(wǎng)交易中的風(fēng)險(xiǎn)是客觀存在的